Shorla Oncology
PrivateLast Round
Series C
Jan 27, 2026
Total Funding Raised
$64.3M
Momentum Score
50 /100
Company Overview
Shorla Oncology is a specialty pharmaceutical company that develops and commercializes innovative oncology drugs, with a focus on orphan and pediatric cancers where existing treatments are limited or in short supply.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shorla Oncology Comps
Public and private peers based on sector, stage, and business model.
Shorla Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 27, 2026 | ||||
| Series B | Oct 4, 2023 | ||||
| Series A | Jun 3, 2020 |
Key People
Founding team and executive leadership
Shorla Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seroba Life Sciences | Series B, Series C, Series A |
| Enterprise Ireland | Series B, Series C, Series A |
| Kurma Partners | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 41% MoM, from 1.8K to 2.6K.
- Jan 27, 2026
$21M round completed.
Shorla Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shorla Oncology's valuation, stock price, and market status.
